Recombinant Mouse SMAD4 Protein, N-His

SMAD4 is a pivotal protein in the transforming growth factor-beta (TGF-β) signaling pathway, playing a crucial role in mediating cellular responses to TGF-β and related cytokines. It acts as a common mediator for signals that regulate key biological processes, including cell growth, differentiation, and apoptosis. Dysregulation of SMAD4 has been implicated in various human diseases, particularly in cancers such as pancreatic and colorectal tumors, where mutations or deletions of the SMAD4 gene are common. Research into SMAD4 recombinant proteins has gained attention as it allows for the exploration of its structural and functional properties, providing insights into the molecular mechanisms underlying TGF-β signaling. These studies enhance our understanding of cancer biology and could lead to the development of novel therapeutic strategies targeting SMAD4 and its signaling pathways. Moreover, the availability of recombinant SMAD4 proteins facilitates the study of protein interactions, post-translational modifications, and the identification of potential small molecules that can modulate its activity, promising avenues for therapeutic intervention in SMAD4-related malignancies. As the need for targeted cancer therapies intensifies, ongoing research into the characterization and functional analysis of SMAD4 recombinant proteins is vital for uncovering its potential as a biomarker and therapeutic target in clinical oncology.